Neochem Bio Solutions Limited
Neochem Bio Solutions conducted its FY26 and H2 FY26 earnings call, showcasing robust financial performance including 32% YoY revenue growth to Rs.110.7 cr and 62% PAT growth to Rs.12 cr. The company also discussed strategic initiatives and improved capacity utilization.
May 27 2026 18:32:05
Neochem Bio Solutions Limited
Neochem Bio Solutions has scheduled a board meeting on May 18, 2026, to approve its audited financial results for the half year and full year ended March 31, 2026. This meeting will finalize the company's financial performance for the period.
May 11 2026 18:14:28
Neochem Bio Solutions Limited
Neochem Bio Solutions board is scheduled to meet on May 18, 2026, to consider and approve its audited standalone half-yearly financial results for the period ended March 2026. This meeting will finalize the company's performance for the second half of the fiscal year 2026.
May 09 2026 11:31:45
Neochem Bio Solutions Limited
Neochem Bio Solutions board is scheduled to meet on May 18, 2026, to consider and approve its audited standalone half-yearly financial results for the period ended March 2026. This meeting will finalize the company's performance for the second half of the fiscal year 2026.
May 09 2026 11:31:24
Neochem Bio Solutions Limited
Neochem Bio Solutions has scheduled a board meeting on May 18, 2026, to approve its audited financial results for the half year and full year ended March 31, 2026. This meeting will finalize the company's financial performance for the period.
May 09 2026 11:14:17
Read More